Cala Health is a bioelectronic medicine company focused on wearable neuromodulation therapies. Grown from Stanford University’s Neuromuscular Biomechanics laboratory, their ultimate goal is to develop neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health’s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
